EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
东部肿瘤合作组 - 威斯康星州研究
基本信息
- 批准号:7869601
- 负责人:
- 金额:$ 61.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-06-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectCancer BurdenCategoriesClinicalClinical ResearchClinical TrialsCommitComprehensive Cancer CenterData QualityEarly DiagnosisEastern Cooperative Oncology GroupEvaluationFacultyGrantHumanIndividualInstitutionLeadershipMalignant NeoplasmsOutcomeParticipantPatientsPopulationPreventionResearchSystemTranslationsUniversitiesWarWisconsincancer carecancer therapydesignimprovedprograms
项目摘要
DESCRIPTION (provided by applicant): This application seeks support for the activities of the Eastern Cooperative Oncology Group (ECOG) at the UW Paul P. Carbone Comprehensive Cancer Center (UWCCC). Over the past 30 years, the UWCCC has maintained exemplary main institution accrual and strong affiliate participation while providing high quality data and key scientific leadership. Institutional evaluations consistently rank the UW ECOG program at or near the top in categories of accrual, administrative, and scientific leadership. The basic, translational, and clinical research programs of the UWCCC are designed to reduce the cancer burden on the population by improving prevention, early detection, and treatment of cancer. The UWCCC commitment to cancer care and research has never been stronger. During the current grant cycle, we have tripled our clinical space and doubled our research space, representing an institutional commitment of nearly $100 million, and increased our cancer focused faculty by nearly 50%. The UWCCC faculty views the NCI cooperative groups as essential components in the war on cancer. Translation of scientific discovery to human populations and to individual patients requires an ability to conduct large scale clinical trials in a timely fashion. ECOG provides this vital forum and the UWCCC remains highly committed to its mutually beneficial partnership with ECOG.
RELEVANCE: ECOG clinical trials are a vitally important cancer treatment option for the citizens of Wisconsin. Group trials represent a proven system for improving outcomes for patients affected by cancer and the University of Wisconsin and its ECOG affiliates remain enthusiastic participants in the cooperative group system.
描述(由申请人提供):本申请为UW Paul P. Carbone综合癌症中心(UWCCC)的东部合作肿瘤小组(ECOG)的活动寻求支持。在过去的30年里,UWCCC在提供高质量数据和关键科学领导的同时,保持了模范的主要机构积累和强大的附属机构参与。机构评估一直将西澳大学ECOG项目在收益,行政和科学领导方面排名最高或接近最高。UWCCC的基础、转化和临床研究项目旨在通过改善癌症的预防、早期发现和治疗来减轻人们的癌症负担。UWCCC对癌症护理和研究的承诺从未如此坚定。在目前的拨款周期中,我们的临床空间增加了两倍,研究空间增加了一倍,这代表了近1亿美元的机构承诺,并将我们的癌症研究人员增加了近50%。UWCCC的教职员工将NCI合作小组视为抗癌战争的重要组成部分。将科学发现转化为人类群体和个体患者需要及时进行大规模临床试验的能力。ECOG提供了这个重要的论坛,UWCCC仍然高度致力于与ECOG的互利伙伴关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brad Kahl其他文献
Brad Kahl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brad Kahl', 18)}}的其他基金
Phase I Study of Rituximab with L2-7001 (Aldesleukin) for Non-Hodgkin's Lymphoma
利妥昔单抗联合 L2-7001(Aldesleukin)治疗非霍奇金淋巴瘤的 I 期研究
- 批准号:
7043907 - 财政年份:2003
- 资助金额:
$ 61.48万 - 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
东部肿瘤合作组 - 威斯康星州研究
- 批准号:
7661563 - 财政年份:1978
- 资助金额:
$ 61.48万 - 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
东部肿瘤合作组 - 威斯康星州研究
- 批准号:
8284229 - 财政年份:1978
- 资助金额:
$ 61.48万 - 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
东部肿瘤合作组 - 威斯康星州研究
- 批准号:
8465828 - 财政年份:1978
- 资助金额:
$ 61.48万 - 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
东部肿瘤合作组 - 威斯康星州研究
- 批准号:
7426841 - 财政年份:1978
- 资助金额:
$ 61.48万 - 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
东部肿瘤合作组 - 威斯康星州研究
- 批准号:
8079081 - 财政年份:1978
- 资助金额:
$ 61.48万 - 项目类别:
相似海外基金
Characterizing Breast and Cervical Cancer Burden Among Sexual Minority women
性少数女性乳腺癌和宫颈癌负担的特征
- 批准号:
10739450 - 财政年份:2023
- 资助金额:
$ 61.48万 - 项目类别:
An mHealth Positive Psychology Intervention to Reduce Cancer Burden in Young Adult Cancer Survivors
移动医疗积极心理干预可减少年轻成年癌症幸存者的癌症负担
- 批准号:
10684909 - 财政年份:2022
- 资助金额:
$ 61.48万 - 项目类别:
An mHealth Positive Psychology Intervention to Reduce Cancer Burden in Young Adult Cancer Survivors
移动医疗积极心理干预可减少年轻成年癌症幸存者的癌症负担
- 批准号:
10458257 - 财政年份:2022
- 资助金额:
$ 61.48万 - 项目类别:
Colorado's Partnership to Implement Evidence-Based Interventions to Reduce the Cancer Burden
科罗拉多州合作实施循证干预措施以减少癌症负担
- 批准号:
10409393 - 财政年份:2021
- 资助金额:
$ 61.48万 - 项目类别:
Reducing Colorectal Cancer Burden in Young Adults: Precision Prevention and Early Detection
减少年轻人结直肠癌负担:精准预防和早期发现
- 批准号:
nhmrc : 1194392 - 财政年份:2020
- 资助金额:
$ 61.48万 - 项目类别:
Investigator Grants
Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals
使用来自大型临床数据研究网络的电子健康记录来了解跨性别者和性别不合格 (TGNC) 个体的癌症负担和癌症风险
- 批准号:
10056679 - 财政年份:2020
- 资助金额:
$ 61.48万 - 项目类别:
Addressing the Cancer Burden in South America and the US Hispanic and Native American Populations through Clinical Trials
通过临床试验解决南美洲以及美国西班牙裔和美洲原住民人口的癌症负担
- 批准号:
9759602 - 财政年份:2019
- 资助金额:
$ 61.48万 - 项目类别:
Cancer Burden attributable to non-modifiable factors in Japan
日本的癌症负担归因于不可改变的因素
- 批准号:
19H03913 - 财政年份:2019
- 资助金额:
$ 61.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Link, monitor, strategize: First Nations, Inuit, Métis peoples' cancer burden in Canada
联系、监测、制定战略:加拿大原住民、因纽特人、梅蒂斯人的癌症负担
- 批准号:
391658 - 财政年份:2018
- 资助金额:
$ 61.48万 - 项目类别:
Operating Grants
Understanding cancer burden and outcomes for Canadians living with intellectual and developmental disabilities
了解患有智力和发育障碍的加拿大人的癌症负担和结果
- 批准号:
389200 - 财政年份:2018
- 资助金额:
$ 61.48万 - 项目类别:
Operating Grants














{{item.name}}会员




